Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
FAM111B encodes a nuclear trypsin-like serine protease involved in DNA repair, cell cycle regulation, and apoptosis. Heterozygous mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP) (Gene Symbol; Disease Name).
Autosomal dominant FAM111B variants have been reported in 36 probands from five unrelated families, with segregation observed in each kindred PMID:35122327. Recurrent missense alleles cluster in the predicted protease domain, including c.1247T>C (p.Phe416Ser) in three families PMID:26471370 and c.1861T>G (p.Tyr621Asp) in a sporadic South African patient PMID:36610347.
Clinically, early-onset poikiloderma (HP:0001029), hypotrichosis and hypohidrosis (HP:0000966) occur in >90% of cases, alopecia (HP:0001596) in 86%, myopathy (HP:0003198) in 53%, and adult-onset pulmonary fibrosis (HP:0002206) in 47% of patients with protease-domain mutations PMID:35122327.
Functional assays show that POIKTMP-associated FAM111B mutants hyperactivate protease function, displace key replication and transcription factors from chromatin, and trigger aberrant apoptosis and genomic instability (PMID:32776417; PMID:37342232). Patient fibroblasts harboring c.1861T>G (p.Tyr621Asp) exhibit reduced FAM111B expression, altered nuclear localization, impaired apoptosis, and dysregulated proliferation PMID:36610347.
Integration of genetic segregation, recurrent dominant-negative or gain-of-function alleles, and concordant in vitro dysfunction supports a Strong gene-disease association. Additional studies reinforce a shared protease-driven mechanism with FAM111A mutants, but exceed current ClinGen scoring.
Key Take-Home: FAM111B sequencing is clinically indicated for patients presenting with early-onset poikiloderma, tendon contractures, muscle weakness, and pulmonary fibrosis to enable accurate diagnosis and guide potential targeted interventions.
Gene–Disease AssociationStrong36 probands, 5 families, concordant functional data Genetic EvidenceStrong36 probands in 5 families with dominant missense and in-frame deletion variants reaching genetic cap Functional EvidenceModerateIn vitro models show hyperactive protease activity, disrupted apoptosis, and telomere instability in mutant FAM111B |